Physician profile
Kavitha Reddy
NPI 1174515084
$1,442.09
in general payments reported to CMS, 2019-2025
13 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $968 · 2020: $130 · 2021: $47.14 · 2022: $30.83 · 2023: $19.75 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $776.11 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $153.65 | 2025 | |
| Bioventus LLC | $117.48 | 2019-2025 | Xcell, Gelsyn-3, Supartz Fx Sodium Hyaluronate |
| Janssen Pharmaceuticals, INC | $95.86 | 2019 | |
| Pacira Therapeutics, INC. | $94.00 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $45.31 | 2020 | |
| Novo Nordisk INC | $34.13 | 2020-2021 | |
| Grt US Holding, INC. | $32.43 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $30.83 | 2022 | |
| Si-Bone, INC. | $21.66 | 2025 | |
| Acacia Pharma INC | $15.27 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.81 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kavitha Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.